CHANDIGARH: Mucormycosis instances are increasing despite the drop in Covid patients.
You’ve been 414 such instances from town until date, with approximately 15 being reported every day on an average.
Patients are arriving from adjacent states of Punjab, Haryana and Himachal Pradesh into PGI and Government Medical College and hospital (GMCH), Sector 32, as May 10.
Treating doctors and microbiologists stated nonbranded antifungal medications are in lack because of unavailability of active pharmaceutical ingredients (API) required for its production that are mostly imported from China.
The number of antifungal drugs keeps going down and up.
Gilead is providing nearly alternate days.
Common is facing difficulty of API from China.
Sometimes spurious amphotericin b lipid emulsion is sold from the source.
Therefore, I am content using amphotericin b deoxycholate,” explained Prof Arunaloke Chakrabarthi, head, department of microbiology, PGI.
Doctors don’t promote the use of both amphotericin b deoxycholate substantially as it seriously impacts the operation of kidneys.
“We will need to track the renal works while the individual is about such a medication.
But there isn’t any use in providing incomplete doses because the disease is extremely innovative,” explained Prof Jagdish Chandra, microbiologist in GMCH.
Prof Jagdish whose authored several books about the fungal disease explained,”With more than 200 vials per day that has been provided, it barely meets the requirements of over two patients who require at 2gm of this injectable medication.
When they don’t finish the program, the disease will spread into the eyes and mind resulting in death”